awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34645665-225FAFAE-02EB-4B73-A7BA-AD6779FF3CA9
Q34645665-225FAFAE-02EB-4B73-A7BA-AD6779FF3CA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34645665-225FAFAE-02EB-4B73-A7BA-AD6779FF3CA9
Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.
P2860
Q34645665-225FAFAE-02EB-4B73-A7BA-AD6779FF3CA9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34645665-225FAFAE-02EB-4B73-A7BA-AD6779FF3CA9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
eea1e4a20787b19be76b9fcb874f2f475c806843
P2860
Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncol